comparemela.com

Effective Orifice Area News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

Anteris Technologies fields excellent 30-day haemodynamic results for DurAVR™ THV in US early feasibility study

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has released 30-day data described as "excellent" from its US early feasibility study (EFS) for the DurAVR™.

Biotechs play the long game as always in a healthy June quarter

Anteris Technologies Ltd hails excellent DurAVR™ THV results in new patient cohort

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) continues to receive "exceptional" patient outcomes for the first-in-human study of its novel DurAVR™.

Anteris Technologies Ltd delivers strong 12-month results from DurAVR™ FIH study

Anteris Technologies Ltd delivers strong 12-month results from DurAVR™ FIH study
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.